Composition
- Active ingredients
- AMPHETAMINE EQ 1.25MG BASE/ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA204325.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Adzenys ER
- Active substance
- amphetamine
- Drug class
- Centrally acting sympathomimetics
- Group
- Stimulants
- Route
- Oral
- Dosage form
- Suspension, extended release
- Applicant
- Neos Theraps Inc
- Status
- Discontinued
- FDA approval
- 15 Sept 2017